The clinical characteristics of recurrent benign paroxysmal positional vertigo
Article Sidebar
Main Article Content
Abstract
Objective:
To study clinical characteristics of recurrent BPPV patients and the 5 years disease-free of recurrence in BPPV.
Study design: A retrospective cohort study
Material and Methods:
Patients who were diagnosed with BPPV from 2008 – 2018 with documented a positive Dix-Hallpike and Supine roll test by otolaryngologists at the outpatient department were retrospectively included.
Results:
A total of 597 patients were identified. 273 patients (45.7 %) had a recurrence disease with an average age 57.4 ± 13.3 years. The duration of symptoms before diagnosis was 5(3,14) days. Almost all patients had the same ear recurrence and the most recurrent site was the right posterior semicircular canal. The median time to recurrence was 6.8 months. About 42.3 % of the patients had a disease-free in 12 months, 29.7% in 2 years, 19.5 % in 3 years, 13.8 % in 4 years, and 10.8% in 5 years. Many associated diseases for example hypertension, dyslipidemia, Meniere disease were not related to the recurrence. The strongly associated factors were female sex, the clinical presentation of disequilibrium comparing with vertigo, positional change association, a number of treatment sessions until objectively negative DHT more than 3 times, and the shorter interval of a recurrent episode.
Conclusion:
The clinical characteristics of recurrent disease were female sex, clinical presentation as disequilibrium, positional change association on an episode, a number of treatment sessions until objectively negative DixHall-pike more than 3 times, and the interval of recurrent episode less than 14 days
Keywords: benign paroxysmal positional vertigo, recurrence pattern
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ต้นฉบับที่ส่งมาพิจารณายังวารสารหู คอ จมูก และใบหน้า จะต้องไม่อยู่ในการพิจารณาของวารสารอื่น ในขณะเดียวกันต้นฉบับที่จะส่งมาจะผ่านการอ่านโดยผู้ทรงคุณวุฒิ หากมีการวิจารณ์หรือแก้ไขจะส่งกลับไปให้ผู้เขียนตรวจสอบแก้ไขอีกครั้ง ต้นฉบับที่ผ่านการพิจารณาให้ลงตีพิมพ์ถือเป็นสมบัติของวารสารหู คอ จมูกและใบหน้า ไม่อาจนำไปลงตีพิมพ์ที่อื่นโดยไม่ได้รับอนุญาต
ตารางแผนภูมิ รูปภาพ หรือข้อความเกิน 100 คำที่คัดลอกมาจากบทความของผู้อื่น จะต้องมีใบยินยอมจากผู้เขียนหรือผู้ทรงลิขสิทธิ์นั้นๆ และใหร้ะบุกำกับไว้ในเนื้อเรื่องด้วย
References
2. Parham K. Benign paroxysmal positional vertigo: an integrated prospective. Adv Otorhinolaryngol2014;1:1-17.
3. Moon SY, Kim JS, Kim BK, Kim JI, Lee H, Son S, et al. Clinical characteristics of benign paroxysmal positional vertigo in Korea: a multicenter study. J Korean Med Sci2006;20:539-43.
4. Caldas MA, Gananca CF, Gananca FF, Gananca MM, Caivilla HH. Clinical features of benign paroxysmal positional vertigo. Braz J Otorhinolaryngol 2009;9:502-6.
5. Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int 2013;7:505-16.
6. Perez P, Franco V, Cuesta P, Aldama P, Alvarez MJ, Mendez JC. Recurrence of benign paroxysmal positional vertigo. Otol Neurotol 2012;2:437-43.
7. Bhattacharyya N, Gubbels SP, Schwartz SR, Edlow JA, El-kashlan J, Fife T, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg;156:S1-47.
8. Rodrigues DL, Ledesma AL, Oliveira CA, Junior FB. Physical therapy for posterior and horizontal canal benign paroxysmal positional vertigo: long term effect and recurrence: a systematic review. Int Arch Otorhinolaryngol 2017;7:455-9.
9. Giometti G, Lapenna R, Panichi R, Mobaraki PD, Longari F, Ricci G, et al. Residual dizziness after successful repositioning maneuver for idiopathic benign paroxysmal positional vertigo : a review. Audiol Res2017;8:31-7.
10. Do YK, Kim J, Park CY, C MH, Moon IS, Yang HS. The effect of early canalith repositioning on benign paroxysmal positional vertigo on recurrence. Clin Exp Otorhinolaryngol 2011;3:113-7.
11. Stefano AD, Dispenza F, Suarez H, Fernandez NP, Huarte RM, Ban JH, et al.
A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx 2014;41:31-6.
12. Wei W, Sayyid ZN, Ma X, Wang T, Dong Y. Presence of anxiety and depression symptoms affects the first time treatment efficacy and recurrence of benign paroxysmal positional vertigo. Front Neurol 2018;9:1-8.
13. Dorigueto RS, Mazzetti KR, Gabilan YP, Gananca FF. Benign paroxysmal positional vertigo recurrence and persistence. Braz J Otorhinolaryngol 2009;10:556-72.
14. Nunez RB, Cass SP, Furman JM. Short and long term outcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg2000;8:647-53.
15. Yoon J, Lee JB, Lee HY, Lee BD, Lee CK, Choi SJ. Potential risk factors affecting repeated canalith repositioning procedures in benign paroxysmal positional vertigo. Otol Neurotol 2017;16:206-11.
16. Hoseinabadi R, Pourbakht A, Yazdani N, Kouhi A, Kamali M, Abdollahi FZ, et al. The effects of the vestibular rehabilitation on the benign paroxysmal positional vertigo recurrence rate in patients with otolith dysfunction. J Audiol Otol 2018;4:204-8.
17. Webster G, Sens PM, Salmito MC, Cavalcante JD, Santos PR, Silva AL, et al. Hyperinsulinemia and hyperglycemia: risk factor for recurrence of benign paroxysmal positional vertigo. Braz J Otorhinolaryngol 2015;15:347-51.
18. Cohen HS, Kimball KT, Stewart MG. Benign paroxysmal positional vertigo and comorbid conditions.ORL J Otorhinolaryngol Relat Spec2004;32:11-5.
19. Hemenway WG, Lindsay JR. Postural vertigo due to unilateral sudden partial loss of vestibular function. Ann Otol Rhino Larygol 1956:65;692-706.
20. Yang CJ, Kim Y, Lee HS, Park HJ. Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo. J Vestib Res2017;27:287-94.
21. Talaat HS, Kabel AH, Khaliel LH, Abuhadied G, El-Naga HB, Talaat AS. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx 2015;42:1-4.
22. Martellucci S, Pagliuca G, Vincentiis M, Greco A, Virgilio AD, Benedetti FM, et al. Features of residual dizziness after canalith repositioning procedures for benign paroxysmal positional vertigo. Otol Neurotol 2016;15:693-701.
23. Kim HJ, Kim JS. The pattern of recurrence in idiopathic benign paroxysmal positional vertigo and self-treatment evaluation. Front Neurol 2017;8:1-8.
24. Moon SY, Kim JS, Kim BK, Kim JI, Lee H, Son S, et al. Clinical characteristics of benign paroxysmal positional vertigo in Korea: a multicenter study. J Korean Med Sci2006;20:539-43.
25. Wee TK, Lorne SP, Richard AC. Otoconia and otolithic membrane fragments within the posterior semicircular canal in benign paroxysmal positional vertigo. Laryngoscope 2017;127:709-14.
26. Barin K, Dodson E. Dizziness in the elderly. Otolaryngol Clin North Am2011;44:437-54.
27. Babac K, Djeric D, Petrovic-Lazic M, Arsovic N, Mikic A. Why do treatment failure and recurrence ofbenign paroxysmal positional vertigo occur?. Otol Neurotol 2014;35:1105-10.
28. Macias JD, Lambert KM, Massingale S, Ellensohn A, Fritz JA. Variables affecting treatment in benign paroxysmal positional vertigo. Laryngoscope 2000:110;1921-4.
29. Koji O, Mamoru S, Shigetaka S, Ujimoto K, Taro I, Yoichi I, et al. Model
experiments of otoconia stability after canalith repositioning procedure of BPPV.
Acta Otolaryngol 2010:130; 804-9